georgejj - we have a couple of trials that may soon report out an update.
Clinical Trials... What's Next !!!........
Inhaled Zyesami - 144 participants Inhaled ZYESAMI™ (Aviptadil Acetate) for the Treatment of Severe COVID-19 (AVICOVID-2) Estimated Primary Completion: Dec 15, 2021 Estimated Study Completion: Dec 31, 2021 https://clinicaltrials.gov/ct2/show/NCT04360096
Inhaled Aviptadil - 82 participants Inhaled Aviptadil for the Treatment of COVID-19 in Patients at High Risk for ARDS Estimated Primary Completion: Dec 2021 Estimated Study Completion: Apr 2022 https://clinicaltrials.gov/ct2/show/NCT04536350